Gene editing technology for treatment-resistant cancer could be a scientific layup' to treat other diseases

For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia.A month afterward, 13-year-old Alyssa was in remission, and she continues to do well several months later.The treatment is a modification of chimeric antigen receptor, or CAR, T-cell therapy.

Read at www.cnn.com